Bernadette Y. Hsu

Bernadette Y. Hsu

Auto-generated profile, based on publicly available information

Bernadette Y. Hsu

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA; Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2018 in Nature
Verified
Journal Article
Closed access
PDF file
JSJohanna R. Schaub
Johanna R. Schaub
KHKari A. Huppert
Kari A. Huppert
SKSimone N. T. Kurial
Simone N. T. Kurial
BHBernadette Y. Hsu
Bernadette Y. Hsu
ACAshley E. Cast
Ashley E. Cast
HWHolger Willenbring
Holger Willenbring

1 January 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
FCFeng Chen
Feng Chen
RJRobert J. Jimenez
Robert J. Jimenez
KSKhushbu Sharma
Khushbu Sharma
HLHubert Y. Luu
Hubert Y. Luu
BHBernadette Y. Hsu
Bernadette Y. Hsu
HWHolger Willenbring
Holger Willenbring

17 June 2014 in Science Signaling
Verified
Journal Article
Closed access
PDF file
Yongho BaeYongho Bae
Yongho Bae
KMKeeley L. Mui
Keeley L. Mui
BHBernadette Y. Hsu
Bernadette Y. Hsu
SLShu-Lin Liu
Shu-Lin Liu
ACAlexandra Cretu
Alexandra Cretu
RARichard K. Assoian
Richard K. Assoian
A signaling pathway triggers cell proliferation in response to increased stiffness in the external environment.

1 June 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
MRMilad Rezvani
Milad Rezvani
RERegina Español-Suñer
Regina Español-Suñer
YMYann Malato
Yann Malato
LDLaure Dumont
Laure Dumont
AGAndrew A. Grimm
Andrew A. Grimm
HWHolger Willenbring
Holger Willenbring

11 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BHBernadette Y Hsu
Bernadette Y Hsu
Yongho BaeYongho Bae
Yongho Bae
KMKeeley L Mui
Keeley L Mui
SLShu-Lin Liu
Shu-Lin Liu
RARichard K Assoian
Richard K Assoian
Apolipoprotein E3 (apoE3) is thought to protect against atherosclerosis by enhancing reverse cholesterol transport. However, apoE3 also has cholesterol-independent effects that contribute to its anti-atherogenic properties. These include altering extracellular matrix protein synthesis and inhibiting vascular smooth muscle cell proliferation. Both of these cholesterol-independent effects result from an apoE3-mediated induction of cyclooxygenase-2 (Cox2). Nevertheless, how apoE3 regulates Cox2 remains unknown. Here, we show that apoE3 inhibits the activation of Rho, which reduces the formation of actin stress fibers and focal adhesions and results in cellular softening. Inhibition of Rho-Rho kinase signaling or direct cellular softening recapitulates the effect of apoE3 on Cox2 expression while a constitutively active Rho mutant overrides the apoE3 effect on both intracellular stiffness and Cox2. Thus, our results describe a previously unidentified mechanism by which an atheroprotective apolipoprotein uses Rho to control cellular mechanics and Cox2.